As part of the International Cooperative Biodiversity Group (ICBG) program, in a search for antiproliferative compounds, an ethanol extract of Polyscias duplicata was investigated due to its antiproliferative activity against the A2780 human ovarian cell cancer line (IC 50 6 g/mL). Seven known oleanane glycosides, 3-[(-L-arabinopyranosyl)oxy]-16-hydroxyolean-12-en-28-oic acid (1, IC 50 8 M), 3-[(-L-arabinopyranosyl)oxy]-16,23-dihydroxyolean-12en-18-oic acid (2, IC 50 13 M), 3-[(O--D-glucopyranosyl-(13)--L-arabinopyranosyl)oxy]-16-hydroxyolean-12-en-28-oic acid (3, IC 50 7 M), 3-[(O--L-rhamnopyranosyl-(12)--L-arabinopyranosyl)oxy]-16-hydroxyolean-12-en-28-oic acid (4, IC 50 2.8 M), 3-[(O--D-glucopyranosyl-(13)--Larabinopyranosyl)oxy]-23-hydroxyolean-12-en-28-oic acid (5, IC 50 10 M), 3-[(O--L-rhamnopyranosyl-(12)--L-arabinopyranosyl)oxy]-23hydroxyolean-12-en-28-oic acid (6, IC 50 3.4 M), and 3-[(-L-arabinopyranosyl)oxy]-23-hydroxyolean-12-en-28-oic acid (7, IC 50 3.4 M) were isolated, and their structures determined using spectroscopic methods.
The International Cooperative Biodiversity Group (ICBG) program was initiated in 1992 by the U.S. National Institutes of Health (NIH) in cooperation with the National Science Foundation (NSF) as a major partner. Other U.S. government agencies (USAID, USDA, DOE) participated at various times over the next 20 years with the latest group of awards (2014-2019) being supported by NIH and NSF alone. The program was managed through the Fogarty International Center (FIC), and the first grants were awarded in 2003. The objectives of the program are described on the FIC website: "The ICBG program supports international, public-private, interdisciplinary research teams in the exploration and discovery of novel compounds and extracts from nature with potential for development as therapeutic agents for multiple disease targets while building research capacity in partnering countries" [2] . Various reviews of the ICBG program have been published [3] .
In a continuing investigation of bioactive constituents of Madagascan plants, as part of the Madagascar ICBG, an ethanol extract of a plant initially identified as Gastonia duplicata Thouars ex Baill. (Araliaceae) was evaluated for antiproliferative activity. It was found to have modest activity against the A2780 ovarian cancer cell line. Work was initiated on this extract in part because there had been no previous phytochemical investigations of plants from the genus Gastonia. Subsequent to the initiation of our work the plant was re-identified as Polyscias duplicata (Thouars ex Baill.) Lowry & G. M. Plunkett, also a member of the Araliaceae family, which contains approximately 1,300 species [4] . Although there has been no published phytochemical work on P. duplicata, the phytochemistry of the genus Polyscias has been well investigated, and members of this genus are known to contain oleanane glycosides [5] . Bioassay-directed fractionation and isolation of the major bioactive constituents led to the identification of seven known oleanane glycosides, which were found to be weakly The crude antiproliferative ethanol extract of P. duplicata (IC 50 6 g/mL) was fractionated using liquid/liquid partitioning, Sephadex LH-20 column chromatography, silica gel column chromatography, and reverse-phase C 18 HPLC to yield seven antiproliferative compounds. Comparison of 13 C NMR data and HRESIMS data with literature values led to their identification as seven oleanane glycosides (Figure 1 [9] , and 3-[(-L-arabinopyranosyl)oxy]-23-hydroxyolean-12en-28-oic acid (7, IC 50 3.4 M) [10] .
The isolated compounds were subjected to antiproliferative bioassay against the A2780 ovarian cancer cell line. The results are shown in Table 1 , and indicate that two of the most active compounds (4 and 6) had a rhamnose at the C2' position. A hydroxyl group at C16 appeared to reduce activity, as indicated by a comparison of 2 and 7. Antiproliferative bioassay: Assay was performed at Virginia Tech according to specifications previously described [11] . The A2780 cell line is a drug-sensitive ovarian cancer cell line [12] . 
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